Search

Hans E Parge

from San Diego, CA
Age ~69
Get Report
Related to:
Jacqueline J Lavenu, 79
Connected to:
Daniel F Pargee, 76Wade Pargeon, 40Neal A Pargman, 80Wilburn E Pargmann, 88Brandy M Pargo, 46Lynn M Pargo, 69Marilyn L Pargo, 63Shelia A Pargo, 70Justin B Pargoff, 43Abigail Parham, 32

Hans Parge Phones & Addresses

  • 1104 Redwood St, San Diego, CA 92103

Work

Company: Proteros biostructures gmbh Mar 2010 to Apr 2012 Position: Business development consultant

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Trinity Business School 1973 to 1982 Specialities: Philosophy

Skills

Drug Discovery • Pharmaceutical Industry • Drug Design • Drug Development • Biotechnology • Life Sciences • Oncology • Lifesciences • Biochemistry • Molecular Biology • Structural Biology • Protein Chemistry • Biopharmaceuticals • Technology Transfer • Cro • Cell Biology • Cancer • Commercialization • Cro Management

Languages

English • German

Interests

Nutraceuticals • Pharmaceuticals • Personal Development • Art and Design • Structure Based Drug Design • Wellness Anti Aging • Health

Industries

Health, Wellness And Fitness

Resumes

Resumes

Hans Parge Photo 1

Medical Liason

View page
Location:
San Diego, CA
Industry:
Health, Wellness And Fitness
Work:
Proteros Biostructures Gmbh Mar 2010 - Apr 2012
Business Development Consultant
Nuskin & Pharmanex Mar 2010 - Apr 2012
Medical Liason
Pfizer 2003 - Mar 2009
Director, Structural Biology
Agouron Jul 1998 - Jul 2003
Group Leader
Agouron Pharmaceuticals Jul 1993 - Jul 1998
Senior Scientist
Education:
Trinity Business School 1973 - 1982
Doctorates, Doctor of Philosophy, Philosophy
Skills:
Drug Discovery
Pharmaceutical Industry
Drug Design
Drug Development
Biotechnology
Life Sciences
Oncology
Lifesciences
Biochemistry
Molecular Biology
Structural Biology
Protein Chemistry
Biopharmaceuticals
Technology Transfer
Cro
Cell Biology
Cancer
Commercialization
Cro Management
Interests:
Nutraceuticals
Pharmaceuticals
Personal Development
Art and Design
Structure Based Drug Design
Wellness Anti Aging
Health
Languages:
English
German

Publications

Us Patents

Pin1 Peptidyl-Prolyl Isomerase Polypeptides, Their Crystal Structures, And Use Thereof For Drug Design

View page
US Patent:
20040171019, Sep 2, 2004
Filed:
Dec 19, 2003
Appl. No.:
10/616003
Inventors:
David Matthews - Encinitas CA, US
Eleanor Dagostino - San Diego CA, US
Rose Ferre - Carlsbad CA, US
Smita Gaur - San Diego CA, US
Chuangxing Guo - San Diego CA, US
Xinjun Hou - San Diego CA, US
Stephen Margosiak - Escondido CA, US
Barbara Mroczkowski - Encinitas CA, US
Grace Nakayama - San Diego CA, US
Hans Parge - San Diego CA, US
Jeff Zhu - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc.
International Classification:
C12Q001/68
C07H021/04
C12N009/64
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 435/226000, 536/023200
Abstract:
Polypeptides containing the PIN1 peptidyl-prolyl isomerase domain but not containing the PIN1 WW domain are described. Also described are crystal structures of these polypeptides, including the crystal structure of a PIN1 PPIase:ligand complex. The structure coordinate data derived from these crystals provides a three-dimensional description of the substrate-binding site of PIN1 peptidyl-prolyl isomerase useful in drug discovery and design for the identification and design of modulators of PIN1 peptidyl-prolyl isomerase activity.

Catalytic Domains Of The Human Hepatocyte Growth Factor Receptor Tyrosine Kinase, And Materials And Methods For Identification Of Inhibitors Thereof

View page
US Patent:
20040009568, Jan 15, 2004
Filed:
Mar 25, 2002
Appl. No.:
10/106938
Inventors:
Barbara Mroczkowski - Encinitas CA, US
Michael Hickey - San Diego CA, US
Michele McTigue - Encinitas CA, US
Brion Murray - San Diego CA, US
Hans Parge - San Diego CA, US
Jay Sarup - San Diego CA, US
Jeff Zhu - Carlsbad CA, US
International Classification:
G06F019/00
G01N033/48
G01N033/50
C12N009/12
C07K014/71
US Classification:
435/194000, 530/350000, 702/019000
Abstract:
The identification, isolation, purification, and characterization of the catalytic domain of the human hepatocyte growth factor receptor kinase (hHGFR) are described. A crystal structure of the hHGFR kinase domain is reported herein. This structure provides a three-dimensional description of the binding site of the hHGFR for structure-based design of small molecule inhibitors thereof as therapeutic agents. The kinase domain of human HGFR and its associated crystal structure is described for use in the discovery, identification and characeterization of modulators of human HGFR.
Control profile
Hans E Parge from San Diego, CA, age ~69 Get Report